Neuroengineers integrate engineering principles with neuroscience to develop technologies that interface with the nervous system. They design brain-computer interfaces (BCIs), neural prosthetics, and bioelectronic devices that can restore sensory or motor functions lost due to injury or disease. Their work involves building systems that decode neural signals and translate them into commands for external devices, offering hope to individuals with paralysis or amputations. Neuroengineers also create wearable or implantable systems that monitor neurological function in real-time for diagnostic and therapeutic use. Through interdisciplinary collaboration with neurosurgeons, neuroscientists, and computer scientists, neuroengineers are advancing brain stimulation technologies for treating disorders like epilepsy, depression, and Parkinson’s disease. They also contribute to the development of closed-loop systems that adjust stimulation based on brain activity feedback. Neuroengineers are key players in translating laboratory innovation into clinical application, driving progress in neuroprosthetics, cognitive enhancement tools, and neural rehabilitation. Their innovations are not only transforming patient care but also expanding our understanding of brain-machine interaction. As neural technology rapidly evolves, neuroengineers remain essential to pushing the boundaries of what’s possible in neurological recovery and augmentation.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Music therapy combined with acupuncture therapy for children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Diquat exposure induces brainstem demyelination and encephalopathy via upregulating the mitochondrial calcium uniporter
Weixia Duan, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, China
Title : Transcranial direct current stimulation (TDCS) for chronic migraine: a randomized clinical trial with 20 patients.
Milton C R Medeiros, Hospital Santa Casa de Arapongas, Brazil
Title : A computational approach to evaluate the impact of chemical pathways on brain activity on a broad scale.
Rahul Hajare, Sandip University, India
Title :
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation